Tushar Misra - 14 Jan 2022 Form 4 Insider Report for Mersana Therapeutics, Inc. (MRSN)

Role
Chief Manufacturing Officer
Signature
/s/ Brian DeSchuytner, as Attorney-in-Fact
Issuer symbol
MRSN
Transactions as of
14 Jan 2022
Net transactions value
$0
Form type
4
Filing time
19 Jan 2022, 17:03:41 UTC
Previous filing
18 Aug 2021
Next filing
18 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRSN Stock Option (right to buy) Award $0 +26,250 $0.000000 26,250 14 Jan 2022 Common Stock 26,250 $6.28 Direct F1
transaction MRSN Restricted Stock Units Award $0 +5,833 $0.000000 5,833 14 Jan 2022 Common Stock 5,833 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in equal quarterly installments over the first four years after the vesting commencement date, January 14, 2022.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock upon vesting.
F3 The restricted stock units vest in equal annual installments over the first four years after the vesting commencement date, January 14, 2022.